Pegfilgrastim biosimilar (Lupin)

非格司亭生物类似药 (Lupin)

Report date: 2025/12/23 09:36:18

Base Information

Drug NamePegfilgrastim biosimilar (Lupin)
Drug Alias NamePegfilgrastimum (Lupin)非格司亭生物仿制药 (Lupin)培非格司亭生物仿制药 (Lupin)Lupifil-PARMLUPEG +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile NeutropeniaNeutropenia
Global Approved IndicationsFebrile NeutropeniaNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2016/01/01
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLupin Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLupin Ltd
Inactive CompaniesN/A
Active IndicationsFebrile NeutropeniaNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A